BR0100949A - Inibição da degradação oxidativa de formulaçõesfarmacêuticas - Google Patents
Inibição da degradação oxidativa de formulaçõesfarmacêuticasInfo
- Publication number
- BR0100949A BR0100949A BR0100949-4A BR0100949A BR0100949A BR 0100949 A BR0100949 A BR 0100949A BR 0100949 A BR0100949 A BR 0100949A BR 0100949 A BR0100949 A BR 0100949A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulations
- inhibition
- oxidation
- pharmaceutical
- oxidative degradation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: "INIBIçãO DA DEGRADAçãO OXIDATIVADE FORMULAçõES FARMACêUTICAS". A invenção fornecemétodos para inibir a degradação oxidativa de formulaçõesfarmacêuticas compreendendo pelo menos um ingrediente dedroga ativo suscetível de oxidação, cujos métodos compreendema adição de uma quantidade inibidora da oxidação de uma fontede íon ferroso, preferivelmente na forma de um excipientefarmacêutico, à formulação. A invenção fornece ainda formulaçõesfarmacêuticas compreendendo pelo menos um ingredientefarmacêutico ativo suscetível de oxidação, e uma quantidadeinibidora da oxidação de uma fonte de íon ferroso, preferivelmentena forma de um excipiente farmacêutico. A invenção fornece aindao uso de uma fonte de íon ferroso como um antioxidante deformulações farmacêuticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18844700P | 2000-03-10 | 2000-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0100949A true BR0100949A (pt) | 2001-10-30 |
Family
ID=22693191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0100949-4A BR0100949A (pt) | 2000-03-10 | 2001-03-09 | Inibição da degradação oxidativa de formulaçõesfarmacêuticas |
Country Status (5)
Country | Link |
---|---|
US (2) | US6423351B2 (pt) |
EP (1) | EP1145719A3 (pt) |
JP (1) | JP2001261577A (pt) |
BR (1) | BR0100949A (pt) |
CA (1) | CA2339705A1 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
WO2004078131A2 (en) * | 2003-03-01 | 2004-09-16 | Symyx Technologies, Inc. | Evaluating effects of exposure conditions on drug samples over time |
TW200526251A (en) | 2003-11-14 | 2005-08-16 | Alza Corp | Minimization of drug oxidation in drug irradiated excipients formulations |
US20070128285A1 (en) * | 2005-07-12 | 2007-06-07 | Chikara Jin | Pharmaceutical composition for oral administration |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US8298565B2 (en) | 2005-07-15 | 2012-10-30 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
PL2019657T3 (pl) | 2006-04-26 | 2015-10-30 | Micell Technologies Inc | Powłoki zawierające wiele leków |
US8636767B2 (en) | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
CN101678388B (zh) | 2006-10-23 | 2013-12-11 | 米歇尔技术公司 | 用于在涂覆过程中为基底充电的保持器 |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
US9433516B2 (en) | 2007-04-17 | 2016-09-06 | Micell Technologies, Inc. | Stents having controlled elution |
EP2170418B1 (en) * | 2007-05-25 | 2016-03-16 | Micell Technologies, Inc. | Polymer films for medical device coating |
MX2010011485A (es) | 2008-04-17 | 2011-03-01 | Micell Technologies Inc | Stents que contienen capas bioadsorbibles. |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
AU2009270849B2 (en) | 2008-07-17 | 2013-11-21 | Micell Technologies, Inc. | Drug delivery medical device |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
EP2411440B1 (en) * | 2009-03-23 | 2018-01-17 | Micell Technologies, Inc. | Improved biodegradable polymers |
JP2012522589A (ja) | 2009-04-01 | 2012-09-27 | ミシェル テクノロジーズ,インコーポレイテッド | 被覆ステント |
EP2531140B1 (en) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
EP2560576B1 (en) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
EP2593039B1 (en) | 2010-07-16 | 2022-11-30 | Micell Technologies, Inc. | Drug delivery medical device |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
CN110269959A (zh) | 2013-03-12 | 2019-09-24 | 脉胜医疗技术公司 | 可生物吸收的生物医学植入物 |
US9155695B2 (en) | 2013-03-14 | 2015-10-13 | Medtronic, Inc. | Injectable ropinirole compositions and methods for making and using same |
CA2912387C (en) | 2013-05-15 | 2019-04-16 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
CA2942239C (en) * | 2014-03-21 | 2020-09-22 | Mylan Laboratories Ltd. | A premix of crystalline raltegravir potassium salt and a process for the preparation thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7400862A (en) * | 1974-01-22 | 1975-07-24 | Cornelis Moerman Dr | Anti tumour compsns. - contain vitamins E and A and ferrous salts |
GB1518364A (en) | 1976-05-05 | 1978-07-19 | Beecham Group Ltd | Pharmaceutical composition |
US5002779A (en) * | 1989-11-07 | 1991-03-26 | The Procter & Gamble Company | Dry stable chocolate beverage containing iron and vitamin C |
RU2080114C1 (ru) * | 1994-06-21 | 1997-05-27 | Акционерное общество закрытого типа "Фармакор" | Препарат для лечения туберкулеза |
CN1116927A (zh) * | 1994-08-16 | 1996-02-21 | 湛江制药厂 | 氨基酸全营养素及其生产工艺 |
US6013632A (en) * | 1997-01-13 | 2000-01-11 | Emory University | Compounds and their combinations for the treatment of influenza infection |
US5817047A (en) * | 1997-03-17 | 1998-10-06 | The Procter & Gamble Company | Tampon and method of making same |
-
2001
- 2001-03-06 EP EP01302022A patent/EP1145719A3/en not_active Withdrawn
- 2001-03-08 CA CA002339705A patent/CA2339705A1/en not_active Abandoned
- 2001-03-09 BR BR0100949-4A patent/BR0100949A/pt not_active IP Right Cessation
- 2001-03-09 US US09/803,455 patent/US6423351B2/en not_active Expired - Fee Related
- 2001-03-12 JP JP2001068073A patent/JP2001261577A/ja active Pending
-
2002
- 2002-05-24 US US10/155,157 patent/US6767558B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6767558B2 (en) | 2004-07-27 |
EP1145719A3 (en) | 2001-11-14 |
EP1145719A2 (en) | 2001-10-17 |
US20020183392A1 (en) | 2002-12-05 |
CA2339705A1 (en) | 2001-09-10 |
JP2001261577A (ja) | 2001-09-26 |
US6423351B2 (en) | 2002-07-23 |
US20010047034A1 (en) | 2001-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0100949A (pt) | Inibição da degradação oxidativa de formulaçõesfarmacêuticas | |
BRPI0415121A (pt) | material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida | |
ES2156028T3 (es) | Composiciones que contienen tetrahidrolipstatina | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
ES2137456T3 (es) | Agente de tratamiento de las enfermedades hepato-biliares. | |
AR030185A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas | |
DK1313467T3 (da) | Hidtil ukendte farmaceutiske præparater til indgivelse af N-0923 | |
BR9611802A (pt) | Composições farmacêuticas | |
ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
MY140576A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
BR0115965A (pt) | Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos | |
PT1121127E (pt) | Composicoes farmaceuticas orais contendo buprenorfina | |
SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
MX2008008556A (es) | Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias. | |
AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
IT1320080B1 (it) | Composizione per uso farmaceutico o dietetico. | |
YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
ID18079A (id) | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis | |
FR2887150B1 (fr) | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise | |
ES2190082T3 (es) | Concentrados estables de vitamina c. | |
BRPI0412364A (pt) | composição farmacêutica sólida, compreendendo amisulpride | |
DK1414467T3 (da) | Topisk behandling af mastalgi | |
BRPI0411702A (pt) | uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral | |
ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009. |